Julkunen H, Eronen M
Department of Internal Medicine, Peijas Hospital, Vantaa, Finland.
Arthritis Rheum. 2001 Mar;44(3):647-52. doi: 10.1002/1529-0131(200103)44:3<647::AID-ANR113>3.0.CO;2-I.
To study the long-term outcome of mothers of children with isolated heart block in a defined population.
We reviewed the Finnish hospital registries for patients born between 1950 and 1999 who had been diagnosed as having isolated heart block before the age of 15 years. We identified 101 children with isolated congenital heart block (CHB) and 55 with isolated heart block detected after the newborn period. Eighty-three (91%) of the 91 mothers of children with CHB and 48 (87%) of the 55 mothers of children with heart block detected after the newborn period were studied according to a protocol defining clinical characteristics (mean 9.9 years, range 0-49 years, and mean 22.9 years, range 4-47 years after the index delivery, respectively). Maternal survival was compared with survival in an age-matched population of normal Finnish women.
Before the index delivery, 29 (37%) of the 78 surviving mothers of children with CHB had a self-reported clinical diagnosis of a chronic autoimmune disease, and 55 (71%) had had symptoms, signs, or abnormal laboratory findings suggesting an underlying subclinical disease. Of the 23 mothers who were completely asymptomatic before the index delivery, 10 (13% of the surviving mothers) remained so after a mean followup of 9.6 years (range 0-21 years). In mothers of children with CHB, clinical characteristics different from those of healthy mothers were photosensitivity, fatigue, dry eyes, and dry mouth. Forty-eight (58%) of these 83 mothers developed an autoimmune disease during followup. The most common diagnosis was primary Sjögren's syndrome (22 definite, 11 probable), followed by systemic lupus erythematosus (SLE). The standardized mortality ratio of mothers of children with CHB was 5.1, and 3 of the 5 deaths were associated with SLE. Mothers of children with heart block detected after the newborn period had similar symptoms and signs of autoimmune diseases as the healthy controls, and their standardized mortality ratio was 1.9.
Primary Sjögren's syndrome, either definite or subclinical, is the predominant autoimmune disorder in mothers of children with CHB. Mothers of children with isolated heart block detected after the newborn period do not, as a group, have clinical features suggestive of autoimmune diseases.
研究特定人群中患有孤立性心脏传导阻滞儿童的母亲的长期预后情况。
我们查阅了芬兰医院登记处中1950年至1999年出生、15岁前被诊断为患有孤立性心脏传导阻滞的患者记录。我们识别出101例患有孤立性先天性心脏传导阻滞(CHB)的儿童以及55例在新生儿期后检测出孤立性心脏传导阻滞的儿童。按照定义临床特征的方案,对91例CHB患儿的母亲中的83例(91%)以及55例新生儿期后检测出心脏传导阻滞患儿的母亲中的48例(87%)进行了研究(分别在索引分娩后平均9.9年,范围0 - 49岁,以及平均22.9年,范围4 - 47岁)。将母亲的生存率与年龄匹配的芬兰正常女性人群的生存率进行比较。
在索引分娩前,78例CHB患儿存活母亲中的29例(37%)自我报告有慢性自身免疫性疾病的临床诊断,55例(71%)有提示潜在亚临床疾病的症状、体征或实验室检查异常。在索引分娩前完全无症状的23例母亲中,经过平均9.6年(范围0 - 21年)的随访后,10例(占存活母亲的13%)仍无症状。在CHB患儿的母亲中,与健康母亲不同的临床特征为光敏性、疲劳、干眼和口干。这83例母亲中有48例(58%)在随访期间患上自身免疫性疾病。最常见的诊断是原发性干燥综合征(22例确诊,11例可能),其次是系统性红斑狼疮(SLE)。CHB患儿母亲的标准化死亡比为5.1,5例死亡中有3例与SLE相关。新生儿期后检测出心脏传导阻滞患儿的母亲与健康对照有相似的自身免疫性疾病症状和体征,其标准化死亡比为1.9。
原发性干燥综合征,无论是确诊的还是亚临床的,是CHB患儿母亲中主要的自身免疫性疾病。新生儿期后检测出孤立性心脏传导阻滞患儿的母亲总体上没有提示自身免疫性疾病的临床特征。